“…Some of these genera are well known as producers of relevant antibiotics with clinical applications, including rifamycins from Amycolatopsis mediterranei , vancomycin from Amycolatopsis orientalis , erythromycin from Saccharopolyspora erythraea , teicoplanin from Actinoplanes teichomyceticus , and gentamicin from Micromonospora purpurea [ 17 ]. The importance of minor genera of actinomycetes has been corroborated by the discovery of several novel compounds in the last years [ 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 ], such as kongjuemycins [ 23 ], catellatolactams [ 24 ], and persicamidines [ 25 ], so these genera represent an untapped resource of potential new bioactive natural products [ 17 , 26 ].…”